Form D · Biotechnology

Deep Blue Medical Advances, Inc.

Durham, NC · CIK 0001726572

Offering snapshot reported Sep 22, 2025 · SEC filing

Reported sold
$5.26M
Offering amount: $5.65M
Investors reported
105
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Sep 9, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 22, 2025Initial$5,261,533No comparison105SEC filing
Jun 30, 2022Initial$7,033,711No comparison113SEC filing
Feb 3, 2021Initial$3,443,506No comparison106SEC filing
Jan 28, 2021Initial$1,574,163No comparison73SEC filing
Aug 30, 2018Initial$295,000No comparison18SEC filing
Jan 24, 2018Initial$517,000No comparison18SEC filing

Offering details

Securities
Equity, Option to acquire
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-558261

Source: Form D, filed Sep 22, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Michael Bates Director
Robert Bonczek Director
Brent Duncan Director
Ken Gall Director
Robert Isaacs Director
Howard Levinson Director, Executive
Neil Meyer Director
William Perry Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
701 W. Main St Suite 410
Durham, NC, 27701